Literature DB >> 22330642

Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.

Dawn R Cochrane1, Britta M Jacobsen2, Keith D Connaghan3, Erin N Howe1, David L Bain3, Jennifer K Richer1.   

Abstract

Progesterone receptors (PRs) mediate response to progestins in the normal breast and breast cancer. To determine if liganded PR regulate microRNAs (miRNAs) as a component of their action, we profiled mature miRNA levels following progestin treatment. Indeed, 28 miRNAs are significantly altered by 6h of progestin treatment. Many progestin-responsive genes are putative targets of progestin-regulated miRNAs; for example, progestin treatment decreases miR-29, thereby relieving repression of one of its direct targets, the gene encoding ATPase, Na(+)/K(+) transporting, beta 1 polypeptide (ATP1B1). Thus, liganded PR regulates ATP1B1 through sites in the promoter and the 3'UTR, to achieve maximal tight hormonal regulation of ATP1B1 protein via both transcriptional and translational control. We find that ATP1B1 serves to limit migration and invasion in breast cancer cells. Lastly, we demonstrate that PR itself is regulated by a progestin-upregulated miRNA, miR-513a-5p, providing a novel mechanism for tight control of PR protein expression. Copyright Â
© 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330642      PMCID: PMC4716679          DOI: 10.1016/j.mce.2011.12.020

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  61 in total

1.  Pretranslational regulation of Na-K-ATPase in cultured canine kidney cells by low K+.

Authors:  J W Bowen; A McDonough
Journal:  Am J Physiol       Date:  1987-02

2.  "Footprint" titrations yield valid thermodynamic isotherms.

Authors:  M Brenowitz; D F Senear; M A Shea; G K Ackers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.

Authors:  Dawn R Cochrane; Diana M Cittelly; Erin N Howe; Nicole S Spoelstra; Erin L McKinsey; Kelly LaPara; Anthony Elias; Douglas Yee; Jennifer K Richer
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

4.  Progestin inhibition of progesterone receptor gene expression in human breast cancer cells.

Authors:  I E Alexander; C L Clarke; J Shine; R L Sutherland
Journal:  Mol Endocrinol       Date:  1989-09

5.  MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis.

Authors:  R O Burney; A E Hamilton; L Aghajanova; K C Vo; C N Nezhat; B A Lessey; L C Giudice
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

6.  Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system.

Authors:  K Christensen; P A Estes; S A Oñate; C A Beck; A DeMarzo; M Altmann; B A Lieberman; J St John; S K Nordeen; D P Edwards
Journal:  Mol Endocrinol       Date:  1991-11

7.  Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

Authors:  Agnès Fournier; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

8.  DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast.

Authors:  J Dinny Graham; Patricia A Mote; Usha Salagame; Jessica H van Dijk; Rosemary L Balleine; Lily I Huschtscha; Roger R Reddel; Christine L Clarke
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

9.  Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

Authors:  Ross L Prentice; Rowan T Chlebowski; Marcia L Stefanick; Joann E Manson; Mary Pettinger; Susan L Hendrix; F Allan Hubbell; Charles Kooperberg; Lewis H Kuller; Dorothy S Lane; Anne McTiernan; Mary Jo O'Sullivan; Jacques E Rossouw; Garnet L Anderson
Journal:  Am J Epidemiol       Date:  2008-03-27       Impact factor: 4.897

10.  MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.

Authors:  Aoife J Lowery; Nicola Miller; Amanda Devaney; Roisin E McNeill; Pamela A Davoren; Christophe Lemetre; Vladimir Benes; Sabine Schmidt; Jonathon Blake; Graham Ball; Michael J Kerin
Journal:  Breast Cancer Res       Date:  2009-05-11       Impact factor: 6.466

View more
  21 in total

Review 1.  Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.

Authors:  Sasagu Kurozumi; Yuri Yamaguchi; Masafumi Kurosumi; Miki Ohira; Hiroshi Matsumoto; Jun Horiguchi
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

2.  Progesterone decreases levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers.

Authors:  Anastasia Kariagina; Jianwei Xie; Ingeborg M Langohr; Razvan C Opreanu; Marc D Basson; Sandra Z Haslam
Journal:  Horm Cancer       Date:  2013-08-31       Impact factor: 3.869

3.  miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.

Authors:  Ying Dong; Jing-Wen Si; Wen-Ting Li; Li Liang; Jian Zhao; Mei Zhou; Dong Li; Ting Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.

Authors:  D M Cittelly; J Finlay-Schultz; E N Howe; N S Spoelstra; S D Axlund; P Hendricks; B M Jacobsen; C A Sartorius; J K Richer
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

5.  Impact of progesterone on stem/progenitor cells in the human breast.

Authors:  Heidi N Hilton; Christine L Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-08-08       Impact factor: 2.673

Review 6.  Steroid hormones, steroid receptors, and breast cancer stem cells.

Authors:  Jessica Finlay-Schultz; Carol A Sartorius
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-08-12       Impact factor: 2.673

7.  miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.

Authors:  Yanyu Wei; Wei Lu; Yehua Yu; Yuanmei Zhai; Hezhou Guo; Shaoxin Yang; Chong Zhao; Yanjie Zhang; Jiali Liu; Yuhui Liu; Jian Fei; Jun Shi
Journal:  Oncogene       Date:  2021-04-22       Impact factor: 9.867

Review 8.  The regulation of RNA metabolism in hormone signaling and breast cancer.

Authors:  Xiaofei Wang; Da Yang
Journal:  Mol Cell Endocrinol       Date:  2021-03-10       Impact factor: 4.102

9.  Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Authors:  Martin A Rivas; Leandro Venturutti; Yi-Wen Huang; Roxana Schillaci; Tim Hui-Ming Huang; Patricia V Elizalde
Journal:  Breast Cancer Res       Date:  2012-05-14       Impact factor: 6.466

10.  MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells.

Authors:  Maria Ouzounova; Tri Vuong; Pierre-Benoit Ancey; Mylène Ferrand; Geoffroy Durand; Florence Le-Calvez Kelm; Carlo Croce; Chantal Matar; Zdenko Herceg; Hector Hernandez-Vargas
Journal:  BMC Genomics       Date:  2013-02-28       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.